EFFICACY OFINFLIXIMABIN THE TREATMENTOF CROHN'S DISEASEIN CHILDREN
This paper shows the research results of the biological therapy with chimeric monoclonal antibody to tumor necrosis factor (TNF) (infliximab). 33 children aged 6 to 18 years with various forms of Crohn's disease were enrolled in the study. Therapy duration ranged from 3 months to 1 year or more...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
"Paediatrician" Publishers LLC,
2012-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|